Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Morbidity and Mortality Weekly Reports (MMWRs)

Return to MMWR by Topic

Treatment

Title	Format
Impact of a Shortage of First-Line Antituberculosis Medication on Tuberculosis Control — United States, 2012–2013 MMWR 2013; 62 (No. 20)	PDF [939 KB]
Interruptions in Supplies of Second-Line Antituberculosis Drugs — United States, 2005–2012 MMWR 2013; 62 (No. 2)	PDF [669 KB]
Severe Isoniazid-Associated Liver Injuries Among Persons Being Treated for Latent Tuberculosis Infection — United States, 2004 – 2008 MMWR 2010; 59 (No. 08)	PDF [1.18 KB]
Tuberculosis Control Activities After Hurricane Katrina - New Orleans, Louisiana, 2005 MMWR 2006; 55 (No. 12)	PDF [508 KB]
Mycobacterium tuberculosis Transmission in a Newborn Nursery and Maternity Ward — New York City, 2003 MMWR 2005; 54 (No. RR-50, 1280-1283)	PDF [366 KB]
Tuberculosis Control Activities After Hurricane Katrina - New Orleans, Louisiana, 2005 MMWR 2006; 55 (No. 12)	PDF [508 KB]
Transmission of Mycobacterium tuberculosis Associated with Failed Completion of Treatment for Latent Tuberculosis Infection - Chickasaw County, Mississippi, June 1999-March 2002; MMWR 2003; 52 (No.11)	PDF [475 KB]
Post-Detention Completion of Tuberculosis Treatment for Persons Deported or Released from the Custody of the Immigration and Naturalization Service — United States, 2003 MMWR 2003; 52 (No. 19)	PDF [475 KB]
Notice to Readers: Acquired Rifamycin Resistance in Persons with Advanced HIV Disease Being Treated for Active Tuberculosis with Intermittent Rifamycin-Based Regimens MMWR 2002; 51 (No. 10)	PDF [3.27 MB]
Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations — United States, 2001. MMWR 2001; 50 (No. 34) Original Guidelines	PDF [287 KB]
Fatal and Severe Hepatitis Associated With Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection — New York and Georgia, 2000 MMWR 2001; 50 (No. 15) Original Guidelines	PDF [388 KB]
Tuberculosis Treatment Interruptions — Ivanovo Oblast, Russian Federation, 1999 MMWR 2001; 50 (No. 11)	PDF [162 KB]
Evaluation of a Directly Observed Therapy Short-Course Strategy for Treating Tuberculosis — Orel Oblast, Russian Federation, 1999–2000 MMWR 2001; 50 (No. 11)	PDF [162 KB]
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR 2000; 49 (No. RR–6)	PDF [350 KB]
Notice to Readers Use of Short-Course Tuberculosis Preventive Therapy Regimens in HIV-Seronegative Persons MMWR 1998; 47 (No. 42)	PDF [264 KB]
Impact of HIV Protease Inhibitors on the Treatment of HIV-Infected Tuberculosis Patients with Rifampin MMWR 1996; 45 (No. 42)	PDF [415 KB]
Severe Isoniazid-Associated Hepatitis — New York, 1991–1993 MMWR 1993; 42 (No. 28)	PDF [305 KB]
Improving Adherence to Antituberculosis Therapy - South Carolina and New York. MMWR 1993; 42 (No. 4)	PDF [331 KB]

Archived Treatment

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

Title	Format
Background: Severe and Fatal Liver Injury Connected to Latent TB Treatment (August 30, 2001)	PDF [136 KB]

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed: March 21, 2013
Page last updated: March 20, 2014
Content source:
- Division of Tuberculosis Elimination

Top